Effects of 5-HT1A receptor agonist and antagonist on anxiety in intact and ovariectomized female rats

Acta Physiologica Hungarica

Volumn 91, Issue 3-4, 2004, Pages 175-184

  Fedotova, Julia O ^a   Hartmann, G ^b   Lenard L ^b   Sapronov, N S ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

5 HT1A receptors; 8 OH DPAT; Anxiety; Elevated plus maze; NAN 190; Ovariectomy

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; E 8875; ESTRADIOL; N 3529; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; 1 (2 METHOXYPHENYL) 4 (4 (2 PHTHALIMIDO)BUTYL)PIPERAZINE; 1-(2-METHOXYPHENYL)-4-(4-(2-PHTHALIMIDO)BUTYL)PIPERAZINE; PIPERAZINE DERIVATIVE; SEROTONIN AGONIST; SEROTONIN ANTAGONIST;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; ESTRUS CYCLE; FEMALE; MAZE TEST; NONHUMAN; OVARIECTOMY; RAT; ANIMAL; ANXIETY; PHYSIOLOGY; WISTAR RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; ANXIETY; ESTRADIOL; FEMALE; OVARIECTOMY; PIPERAZINES; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 10344229462     PISSN: 0231424X     EISSN: None     Source Type: Journal    
DOI: 10.1556/APhysiol.91.2004.3-4.1     Document Type: Article

References (31)

1. Kirschenblat YaD (1969): Practice in endocrinology. Science, Moscow.
2. Backstrom T: Neuroendocrinology of premenstrual syndrome. Clin. Obstet. Gynecol. 35, 612-628 (1992)
3. Bethea CL, Lu NZ, Gundlan C, Streicher JM: Diverse actions of ovarian steroids in the serotonin neural system. Front. Neuroendocrinol. 23, 41-100 (2002)
4. Biegon A, McEwen BS: Modulation by estradiol of serotonin receptors in brain. J. Neurosci. 2, 199-205 (1982)
5. Bitran D, Hilvers RJ, Kelogg CK: Ovarian endocrine status modulates the anxiolytic potency of diazepam and the efficacy of gamma-aminobutyric acid-benzodiazepine receptor-mediated chloride ion transport. Behav. Neurosci. 105, 653-662 (1991)
6. Charney DS, Krystal JH, Delgado PL, Heningerg GR: Serotonin-specific drugs for anxiety and depressive disorders. Ann. Rev. Med. 41, 437-446 (1990)
7. Cyr M, Landry M, DiPaolo T: Modulation by estrogen-receptor directed drugs of 5-hydroxytryptamine-2A receptors in rat brain. Neuropsychopharmacol. 23, 69-78 (2000)
8. Dumuis A, Sebben M, Bockaert J: Pharmacology of 5-hydroxytryptamine 1A receptors solubilized in hippocampal and cortical neurons in primary culture. Mol. Pharmac. 33, 178-186 (1988)
9. Fink G, McQeen J, Rose CR, Summer B, Dow R, Graham L, Wilson H: Oestrogen effects mood and mental state by an action on serotonin receptors and the transporter. J. Endocrinol. 152, 130-135 (1997)
10. Fink G, Sumner BE, McQeen J, Wilson H, Rose R: Sex steroid control of mood, mental state and memory. Clin. Exp. Pharmacol. Physiol. 25, 764-775 (1998)
11. Glennon RA: Serotonin receptors: clinical implications. Neurosci. Biobehav. Rev. 14, 35-47 (1990)
12. Graeff FG, Guimaraes FS: Role of 5-HT in stress, anxiety and depression. Pharmacol. Biochem. Behav. 54, 129-141 (1996)
13. Halbreich U: Endocrine psychopharmacology. Neuropsychopharmacol. 23, 14-18 (2000).
14. Handley SL: 5-Hydroxytriptamine pathways in anxiety and its treatment. Pharmacol. and Therap. 66, 1103-1148 (1995)
15. Henderson VW, Paganini-Hill A, Emanuel CK, Dunn ME: Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and non-demented control subjects. Arch. Neurol. 51, 896-900 (1994)
16. Hoyer D, Pazos A, Probst A, Palasios JM: Serotonin receptors in the human brain: I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain Res. 376, 85-96 (1986)
17. Lucki I: 5-HT1 receptors and behavior. Neurosci. Biobehav. Rev. 16, 83-93 (1992)
18. Manswood S, Truitt W, Hotema M, Caldarola-Pastuszka M: Estrous cycle modulation of extracellular serotonin in mediobasal hypothalamus: role of the serotonin transporter and terminal autoreceptors. Brain Res. 831, 146-154 (1999)
19. Martin GR, Eglen RM, Hamblin MW: The structure and signalling properties of 5-HT receptors: an endless diversity? Trends in Pharmacol. Sci. 19, 2-4 (1998)
20. McEwen BS, Alves SE: Estrogen actions in the central nervous system. Endocrine Rev. 20, 279-307 (2000)
21. McQueen JK, Wilson H, Dow RC, Fink G: Oestradiol 17β increases serotonin transporter (SERT) binding sites and SERT mRNA expression in discrete regions of female rat brain. J. Physiol. Proc. 495, 114-119 (1996)
22. Mora S, Dussaubat N, Diaz-Veliz G: Effects of the estrous cycle and ovarian hormones on behavioral indices of anxiety in female rats. Psychoneuroendocrinol. 21, 609-620 (1996)
23. Nomikos GG, Spiraki C: Influence of oestrogen on spontaneous and diazepam-induced exploration of rats in an elevated plus-maze. Neuropharmacol. 27, 691-696 (1988)
24. Pazos A, Palacios JM: Quantitative autographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res. 346, 205-230 (1985)
25. Riekkinen P Jr: 5-HT1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior. Eur. J. Pharmacol. 262, 77-90 (1994)
26. Rodgers RJ, Cao BJ, Dalvi A, Holmes A: Animal models of anxiety: an ethological perspective. Braz. J. Med. Biol. Res. 30, 289-304 (1997)
27. Rubinow DR, Schmidt PJ, Roca CA: Estrogen-serotonin interactions: implications for affective regulation. Biol. Psychiat. 44, 839-850 (1998)
28. Uphouse L, Williams J, Eckolsk K, Sierra V: Cortical changes in serotonin receptors during the female rat estrous cycle. Brain Res. 381, 376-381 (1986)
29. Vaccari A, Brotman S, Cimino J, Timiras PS: Sex differentiation of neurotransmitter enzymes in central and peripheral nervous systems. Brain Res. 132, 176-185 (1977)
30. Verge D, Daval G, Marcinkiewicz M, Patey A, el Mestikawy S, Gozlan H, Hamon M: Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control on 5,7-dihydroxytryptamine-treated rats. J. Neurosci. 6, 3474-3482 (1986)
31. Williams J, Uphouse L: Serotonin binding sites during proestrus and following estradiol treatment. Pharmacol. Biochem. Behav. 33, 615-620 (1989)